Compound Detail
CHEMBL836
TAMSULOSIN 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL836 |
| Name | TAMSULOSIN |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | DRHKJLXJIQTDTD-OAHLLOKOSA-N |
| Therapeutic | ✓ Yes |
22
Targets
75
Activities
4
Assay Types
11
PK Parameters
20
Publications
7
Known Names
11
Indications
Molecular Properties
408.5
MW (Da)
2.34
ALogP
6
HBA
2
HBD
99.9
PSA (Ų)
0.55
QED
0
Ro5 Violations
11
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1997 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Indications
Prostatic Hyperplasia Hyperplasia Kidney Calculi Postoperative Complications Premature Ejaculation Prostatic Neoplasms, Castration-Resistant Ureterolithiasis Urinary Retention Urinary Tract Infections Urolithiasis Erectile Dysfunction
ATC Classification
G04CA02
tamsulosin
Level 1: GENITO URINARY SYSTEM AND SEX HORMONES
Level 2: UROLOGICALS
Activity Summary
Ki 49 meas. best 10.54
Kd 17 meas. best 10.6
IC50 7 meas. best 9.82
EC50 2 meas. best 10.15
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Alpha-1D adrenergic receptor CHEMBL326 | Kd | 10.6 | 10.6 | 0.0 | 1 |
| Alpha-1A adrenergic receptor CHEMBL229 | Ki | 10.54 | 9.7527 | 0.0 | 11 |
| Alpha-1A adrenergic receptor CHEMBL319 | Ki | 10.52 | 10.205 | 0.0 | 2 |
| Adrenergic receptor alpha-1 CHEMBL2094251 | Kd | 10.4 | 9.55 | 0.0 | 4 |
| Alpha-1D adrenergic receptor CHEMBL223 | Ki | 10.24 | 9.652 | 0.1 | 10 |
| Alpha-1D adrenergic receptor CHEMBL326 | Ki | 10.15 | 10.15 | 0.1 | 1 |
| Alpha-1A adrenergic receptor CHEMBL229 | EC50 | 10.15 | 10.15 | 0.1 | 1 |
| Alpha-1A adrenergic receptor CHEMBL4892 | Ki | 9.9 | 9.9 | 0.1 | 1 |
| Alpha-1B adrenergic receptor CHEMBL232 | EC50 | 9.89 | 9.89 | 0.1 | 1 |
| Alpha-1D adrenergic receptor CHEMBL223 | IC50 | 9.82 | 9.335 | 0.1 | 2 |
| Alpha-1A adrenergic receptor CHEMBL3637 | Kd | 9.8 | 9.8 | 0.2 | 1 |
| Alpha-1B adrenergic receptor CHEMBL3122 | Ki | 9.7 | 9.7 | 0.2 | 1 |
| Rattus norvegicus CHEMBL376 | Kd | 9.69 | 9.58 | 0.2 | 2 |
| Alpha-1B adrenergic receptor CHEMBL315 | Kd | 9.69 | 9.69 | 0.2 | 2 |
| D(3) dopamine receptor CHEMBL234 | Ki | 9.55 | 9.55 | 0.3 | 1 |
| Canis familiaris CHEMBL373 | Kd | 9.54 | 9.0933 | 0.3 | 3 |
| Alpha-1A adrenergic receptor CHEMBL229 | Kd | 9.54 | 9.54 | 0.3 | 2 |
| Alpha-1A adrenergic receptor CHEMBL229 | IC50 | 9.49 | 9.075 | 0.3 | 2 |
| Alpha-1A adrenergic receptor CHEMBL319 | Kd | 9.47 | 9.47 | 0.3 | 2 |
| Alpha-1B adrenergic receptor CHEMBL232 | Ki | 9.21 | 8.67 | 0.6 | 9 |
| 5-hydroxytryptamine receptor 1A CHEMBL214 | Ki | 9.1 | 9.1 | 0.8 | 1 |
| Alpha-1 adrenergic receptor CHEMBL2111452 | IC50 | 8.74 | 8.74 | 1.8 | 1 |
| Alpha-1B adrenergic receptor CHEMBL232 | IC50 | 8.38 | 8.35 | 4.2 | 2 |
| Alpha-2B adrenergic receptor CHEMBL266 | Ki | 8.17 | 7.635 | 6.8 | 2 |
| Alpha-2C adrenergic receptor CHEMBL1916 | Ki | 8.1 | 8.1 | 7.9 | 1 |
| D(2) dopamine receptor CHEMBL217 | Ki | 7.89 | 7.5 | 13.0 | 2 |
| Alpha-2A adrenergic receptor CHEMBL1867 | Ki | 7.87 | 7.535 | 13.4 | 2 |
| 5-hydroxytryptamine receptor 7 CHEMBL3155 | Ki | 7.08 | 7.08 | 84.0 | 1 |
| Serotonin 1 (5-HT1) receptor CHEMBL2095159 | Ki | 6.03 | 6.03 | 944.0 | 1 |
| Unchecked CHEMBL612545 | Ki | 6.0 | 6.0 | 1000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 0.62 | mL.min-1.kg-1 | Homo sapiens |
| CL | 0.5 | mL.min-1.kg-1 | Homo sapiens |
| CL | 0.62 | mL.min-1.kg-1 | Homo sapiens |
| CL | 0.62 | mL.min-1.kg-1 | Homo sapiens |
| Fu | 0.01 | - | Homo sapiens |
| Fu | 0.01 | - | Homo sapiens |
| Fu | 0.2 | - | Rattus norvegicus |
| Fu | 0.01 | - | Homo sapiens |
| Fu | 0.2 | - | Rattus norvegicus |
| MRT | 5.6 | hr | Homo sapiens |
| T1/2 | 6.8 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.5281/zenodo.13943903 | ADMET | 89 |
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 20934789 | 10.1016/j.ejmech.2010.09.042 | Unchecked | 12 |
| 20070106 | 10.1021/jm901371v | Homo sapiens | 8 |
| 10841797 | 10.1021/jm9905918 | D(2) dopamine receptor | 6 |
| 10841797 | 10.1021/jm9905918 | Unchecked | 5 |
| 18426954 | 10.1124/dmd.108.020479 | ADMET | 4 |
| 27658792 | 10.1016/j.bmc.2016.09.017 | Rattus norvegicus | 4 |
| 10841797 | 10.1021/jm9905918 | Histamine H1 receptor | 4 |
| 9135028 | 10.1021/jm960697s | Alpha-1D adrenergic receptor | 3 |
| 10841797 | 10.1021/jm9905918 | D(3) dopamine receptor | 3 |
| 10841797 | 10.1021/jm9905918 | Alpha-2B adrenergic receptor | 3 |
| 10841797 | 10.1021/jm9905918 | Alpha-2A adrenergic receptor | 3 |
| 10841797 | 10.1021/jm9905918 | 5-hydroxytryptamine receptor 1A | 3 |
| 10841797 | 10.1021/jm9905918 | Alpha-1A adrenergic receptor | 3 |
| 9135028 | 10.1021/jm960697s | Adrenergic receptor alpha-1 | 3 |
| 9379432 | 10.1021/jm970364a | Alpha-1A adrenergic receptor | 3 |
| 9135028 | 10.1021/jm960697s | Alpha-1B adrenergic receptor | 3 |
| 9135028 | 10.1021/jm960697s | Alpha-1A adrenergic receptor | 3 |
| 10780916 | 10.1021/jm990567u | Rattus norvegicus | 3 |
Data from ChEMBL 36 via Core Engine